Allium® ureteral stent, a new player in the treatment of ureteral stenosis: a prospective cohort study.

Allium® ureteral stent Autoexpandible Estenosis ureteral Minimally invasive Self-expandable Stent ureteral Allium® Tratamiento mínimamente invasivo Ureteral stenosis Urolithiasis Urolitiasis

Journal

Actas urologicas espanolas
ISSN: 2173-5786
Titre abrégé: Actas Urol Esp (Engl Ed)
Pays: Spain
ID NLM: 101771154

Informations de publication

Date de publication:
11 2023
Historique:
received: 19 04 2023
revised: 20 05 2023
accepted: 26 05 2023
medline: 6 11 2023
pubmed: 14 7 2023
entrez: 13 7 2023
Statut: ppublish

Résumé

Ureteral stricture is a chronic condition that can result in the obstruction of urinary drainage from the affected renal unit, leading to loss of renal function. Treatment methods can be categorized into two main headings: endourological and reconstructive procedures. We aimed to investigate the efficacy and safety of the self-expandable Allium® ureteral stent, which has been used in the minimally invasive treatment of ureteral stenosis in recent years. Twenty patients who were applied Allium® ureteral stent between 2017 and 2021 included in the study. The demographic and clinical characteristics of the patients, the details of the treatments applied to the patients, the perioperative and postoperative complications, the treatments applied for the complications and the findings in the follow-up were recorded and evaluated prospectively. Etiology included urolithiasis in 16 patients (80%), malignancy in 3 patients (15%), and a previous gynecological operation in 1 patient (5%). Stent obstruction was found to be the most common complication in 3 patients (15%). Stent migration was the second most common complication in 2 patients (10%). Our follow-up continues with 15 patients without stent-related complications and stent obstruction. The mean follow-up period was 28 ± 15.7 months. Allium ureteral stent is an effective and reliable method in the minimally invasive treatment of ureteral stricture with complications seen at acceptable rates and ease of treatment in the management of complications.

Identifiants

pubmed: 37442223
pii: S2173-5786(23)00088-4
doi: 10.1016/j.acuroe.2023.07.003
pii:
doi:

Types de publication

Journal Article

Langues

eng spa

Sous-ensembles de citation

IM

Pagination

598-604

Informations de copyright

Copyright © 2023 AEU. Published by Elsevier España, S.L.U. All rights reserved.

Auteurs

T Aksakalli (T)

Servicio de Urología, Hospital de Formación e Investigación de Erzurum, Universidad de Ciencias de la Salud, Erzurum, Turkey. Electronic address: tugay.aksakalli@saglik.gov.tr.

S Adanur (S)

Servicio de Urología, Facultad de Medicina, Universidad de Atatürk, Erzurum, Turkey.

S O Demirdogen (SO)

Servicio de Urología, Facultad de Medicina, Universidad de Atatürk, Erzurum, Turkey.

O Polat (O)

Servicio de Urología, Facultad de Medicina, Universidad de Atatürk, Erzurum, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH